02607 SH PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 1.33X | Oper Margin | 4.0% |
|---|---|---|---|
| LT Debt/Equity | 7.1% | Net Margin | 2.0% |
| Total Debt/Equity | 65.2% | Return on Equity | 7.5% |
| Price/Book | 0.52X | Return on Assets | 2.5% |
| (HKD 11.740) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 6,372.01 | 4,841.61 | 4,153.09 | 6,297.95 | 6,229.82 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +31.6 | +16.6 | -34.1 | +1.1 | +16.8 |
| Earnings Per Share (HKD) | 1.718 | 1.307 | 1.122 | 1.808 | 2.192 |
| Earnings Per Share Growth (%) | +31.5 | +16.5 | -38.0 | -17.5 | +16.8 |
| Dividend Per Share (HKD) | 0.522 | 0.404 | 0.441 | 0.664 | 0.492 |
| P/E* (X) | 6.83 | 8.98 | 10.46 | 6.49 | 5.36 |
| Yield (%) | 4.44 | 3.44 | 3.75 | 5.65 | 4.19 |
| Dividend Share (%) | 30.36 | 30.93 | 39.27 | 36.71 | 22.45 |
| Book NAV (HKD) | 22.780 | 20.558 | 20.395 | 20.335 | 21.242 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-05-18 21:40:21
Latest Result
| (RMBMn) | 2026-03 | 2025-03 | Chg* (%) | 2024-03 |
| Cover Period (mths) | 3 | 3 | NA | 3 |
|---|---|---|---|---|
| Turnover | 75,262 | 70,763 | +6.4 | 70,153 |
| Operating Result | 2,219 | 1,931 | +14.9 | 2,101 |
| Associates | 26.996 | 215.829 | -87.5 | 203.279 |
| Profit Before Taxation | 2,419 | 2,153 | +12.4 | 2,417 |
| Taxation | 569.089 | 512.524 | +11.0 | 551.128 |
| Profit /( Loss) After Taxation | 1,850 | 1,640 | +12.8 | 1,866 |
| Minority Interests | 432.349 | 307.123 | +40.8 | 323.295 |
| Net Profit | 1,418 | 1,333 | +6.4 | 1,542 |
| Earnings Per Share () | 0.4313 | 0.3862 | +11.7 | 0.4549 |
| Announcement Date | 2026-04-29 | 2025-04-28 | NA | 2024-04-26 |
* Annualised
Last Update Time: 2026-05-18 21:40:26
